TITLE

SIMON' SAYS

AUTHOR(S)
Brown, Simon
PUB. DATE
April 2013
SOURCE
Finweek;4/11/2013, p20
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The author discusses the investment approaches and performances of various investment companies including Capitec Bank Holdings, Cipla Medpro, and Bidvest. He mentions that the financial results of Capitec showed strong set of records, except for its cost-to-income ratio of 38% that is remarkably low. He says that Cipla Medpro showed increased revenue with decreased earnings. He adds that the proposed deal of Brian Joffe of Bidvest to acquire 60% of Adcock Ingram is masterful.
ACCESSION #
87992714

 

Related Articles

  • Adcock: Still in the game. Ndweni, Buhie // Finweek;1/24/2013, p32 

    The article focuses on the anti-retroviral (ARV) tender obtained by pharmaceutical companies like Adcock Ingram, Aspen Inc., and Cipla Medpro Pty. Ltd. from the South African government in 2012. It says that Adcock gained 14% and will supply 25% to the tender. It adds that Aspen have 20.6% of...

  • Ahead of expectations. ASHTON, MARK // Finweek;8/25/2011, p35 

    The article focuses on the financial performance of Capitec Bank Holdings Ltd.

  • Mind the hype. Whitfield, Bruce // Finweek;5/6/2010, p28 

    The article discusses developments related to Capitec Bank in South Africa. It mentions that the firm has gained consistent demand for their available stock and have earned an increased level of earnings per share which is up by 44% at the end of February 2010. It affirms that the firm is...

  • Tech-savvy model. Whitfield, Bruce // Finweek;5/29/2008, p41 

    The article reports on the market performance of Capitec Bank Holdings in South Africa. The firm has a current market capitalisation of 2.5 billion rand and targets lower income earners, trades on a multiple of 12 times giving it a higher rating than any of the country's Big Four. Factors...

  • SIMON SAYS. Brown, Simon // Finweek;12/13/2012, p20 

    The article offers information related to financial investments. It states that Cipla Medpro has 855c offer from Cipla India but is trading more than 855c level. It notes that the stock price of the investment holding company Huge Group are still being affected by the fair value adjustments of...

  • Dose of growth. HASENFUSS, MARC // Finweek;10/6/2011, p36 

    The article discusses what Cipla Medpro needs to do for growth.

  • Thank you, India. Whitefield, Bruce // Finweek;6/17/2010, p35 

    The article reflects on the relationship between Cipla India and Cipla Medpro P/L in terms of generic drugs distribution.

  • Smaller growth stories.  // Finweek;4/5/2007, p12 

    The article offers financial-related news briefs in the U.S. The excess of JSE Ltd.'s growth stocks requires careful examination through fundamentals. Capitec Bank's growth funds are said to offer useful services. Comair Inc.'s brand SA Airways for its national carrier is said to be a great...

  • Adcock Ingram announces appointment of Brian Joffe as Chairman.  // African Business News;2/26/2014, p10 

    The article reports on personnel changes at Adcock Ingram including the appointment of executive Brian Joffe as non-executive Chairman of the Board of Directors, executive Michael Sacks as an independent non-executive director and Chairman of the Audit Committee and Clifford Raphiri, currently...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics